GitLab stock price target reiterated at $70 by Guggenheim ahead of earnings

Guggenheim reiterated a Buy on GitLab (NASDAQ:GTLB) with a $70 price target (about 64% upside from the current $42.64) ahead of fiscal Q3 2026 results due Dec. 8, forecasting 26% revenue growth (vs. consensus 22%), subscription growth of 27% and SaaS growth of 35%, and highlighting an 88.5% gross margin and >20% free-cash-flow margin to fund go-to-market and product investments such as the Duo Agent Platform. The firm expects GitLab to beat consensus on revenue and earnings and to be profitable this year (EPS ~ $0.85), while Piper Sandler and Cantor Fitzgerald remain bullish and Raymond James and Wolfe Research are more cautious amid persistent takeover rumors involving Datadog. With shares down roughly 8% over the past week, the Dec. 8 earnings release and any M&A developments are the key near-term catalysts for validating the asserted upside.

Analysis

Guggenheim reiterated a Buy on GitLab (GTLB) with a $70 price target, implying roughly 64% upside from the current $42.64, ahead of fiscal Q3 2026 results scheduled for December 8. The firm projects total revenue growth of 26% versus consensus 22%, subscription growth of 27% and SaaS growth of 35%, and notes paid seats have grown double-digits and accelerated over the last four quarters—supporting expectations of beats on revenue and earnings.

InvestingPro data cited in the article shows nearly 29% LTM revenue growth, an 88.52% gross profit margin and over 20% free-cash-flow margin, which Guggenheim argues provide ample flexibility to invest in go-to-market and product initiatives such as the Duo Agent Platform (expected GA by fiscal year-end). Management has prioritized new customer acquisition, faster expansions and platform improvements across DevOps, security and AI, while guidance already factors modest near-term disruption and continued SMB softness.

Near-term catalysts and risks include the December earnings print and persistent M&A rumors involving Datadog valuing GitLab above $60; analyst positioning is mixed with Piper Sandler and Cantor Fitzgerald bullish and Wolfe Research skeptical, and Raymond James at a lower $55 target. Shares have declined about 8.36% over the past week despite 19 analysts revising earnings upward and an EPS forecast of ~$0.85 for profitability this year, indicating positive fundamental revisions but execution- and rumor-driven volatility remain key risks.

Key Decisions for Investors

• Consider a modest buy or add ahead of the Dec. 8 earnings release to capture the analyst-implied upside, but limit position size given execution risk and recent 8.36% share weakness
• Require confirmation from the earnings print—specifically revenue near the 26% Guggenheim forecast, SaaS growth close to 35%, accelerating paid-seat metrics, and EPS/cash-flow beats—before materially increasing exposure
• Monitor M&A signals closely because a credible takeover bid above $60 would be a clear catalyst; absent deal clarity, hedge exposure or use defined-risk option structures to participate in upside while capping downside
• If preferring lower risk, wait for post-earnings management commentary on Duo Agent Platform GA timing and SMB trends before initiating a larger position